During the past few years, numerous in vivo brain proton (1H) magnetic resonance spectroscopy (MRS) Studies have suggested a correlation between pathology and the observable metabolite levels in cancer, epilepsy, Alzheimer's disease, multiple sclerosis, HIV infection, stroke and other disorders of the central nervous system. Unfortunately 1H-MRS still suffers from (a) low voxel signal-to-noise ratio at the desired, sub 1 ml, spatial resolution obtained at a """"""""clinically reasonable"""""""" 40 min. session; (b) spectral contamination by signals from extraneous tissue, due to limitations of current localization methods, especially at high, >3 Tesla, magnetic fields; and (c) scarcity of software to design and interpret results from these experiments. To address these, the first goal of this project is to develop and optimize echo and non-echo 3D localization methods based exclusively on Hadamard spectroscopy imaging (HIS). Using 3D HIS in all directions with either surface or volume-coils will: (a) improve the voxels' profile, hence, intervoxel isolation; (b) intrinsically suppress extraneous contamination; (c) be simple to implement, post-process and display; (d) be suitable for 1H-MRS even at very high, >3 T, magnetic fields, i.e., immune to the chemical shift artifacts associated with selective-pulses; and (e) require fewer encoding steps, thus, execute faster than chemical-shift-imaging based methods. The second goal is to produce platform-independent image-guided radio-frequency pulse-design and data post-processing software for the first goal. The purpose and guiding philosophy is to ensure that the deliverables from this project: pulse-timing sequence templates, pulse design tools, post processing and display software, can be straightforwardly implemented on any modern imager and computing platform. This work will extend both the clinical and biomedical research applications of 1H-MRS by providing increased spatial resolution, shorter acquisition time and 3D localization sequences suited for clinical, <2 Tesla, as well as high, >3 T, magnetic fields. The development will support ongoing studies investigating changes in brain metabolites associated with multifocal and diffuse brain disorders, specifically, multiple-sclerosis, aging, brain trauma, AIDS and pediatric neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS033385-04
Application #
2904726
Study Section
Special Emphasis Panel (ZRG1-DMG (02))
Program Officer
Jacobs, Tom P
Project Start
1996-07-22
Project End
2002-04-30
Budget Start
1999-07-01
Budget End
2000-04-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Filippi, M; Bozzali, M; Rovaris, M et al. (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126:433-7
Li, Belinda S Y; Regal, Juleiga; Soher, Brian J et al. (2003) Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 24:68-74
Gonen, Oded; Moriarty, David M; Li, Belinda S Y et al. (2002) Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations. Radiology 225:261-8
Li, Belinda S Y; Babb, James S; Soher, Brian J et al. (2002) Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 47:439-46
Bonneville, Fabrice; Moriarty, David M; Li, Belinda S Y et al. (2002) Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 23:371-5
Li, B S; Regal, J; Gonen, O (2001) SNR versus resolution in 3D 1H MRS of the human brain at high magnetic fields. Magn Reson Med 46:1049-53
Movsas, B; Li, B S; Babb, J S et al. (2001) Quantifying radiation therapy-induced brain injury with whole-brain proton MR spectroscopy: initial observations. Radiology 221:327-31
Gonen, O; Gruber, S; Li, B S et al. (2001) Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol 22:1727-31
Gonen, O; Grossman, R I (2000) The accuracy of whole brain N-acetylaspartate quantification. Magn Reson Imaging 18:1255-8
Gonen, O; Catalaa, I; Babb, J S et al. (2000) Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology 54:15-9

Showing the most recent 10 out of 17 publications